October 17, 2026 05:59 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism | Meerut blue drum murder case: Muskaan, her lover get death sentence | 'Rise up, young patriots!': American singer Mary Millben alleges CJP gets US funding, urges peaceful protests | 'Won't go unchallenged': Muhammad Yunus heckling in New York triggers legal action warning | flydubai cockpit attack probe widens: Two Maldivian pilots detained in UAE over links to Omani co-pilot
Covidd-19 Vaccine

Vaccine by the end of 2020 possible, says Union health minister

| @indiablooms | Aug 31, 2020, at 10:47 pm

New Delhi/IBNS: Union health and family welfare minister Dr Harshvardhan said on Monday that a vaccine might be ready in the country by the end of this year, said media report.

The minister said India is not lagging behind anyone else in the world in efforts to contribute towards the development of a coronavirus vaccine.

There are 7-8 vaccine candidates, three of them in the clinical trial phase and the rest in the pre-clinical phase, he informed.

Currently, two vaccine candidates developed in India — Covaxin by Bharat Biotech and ZyCoV-D by Zydus Cadila are in the midst of phase II clinical trial, while Covishield by the University of Oxford has recently started the phase II clinical trial in India.

Vaccine manufacturer AstraZeneca has entered into an agreement with Serum Institute of India to manufacture Oxford's COVID-19 vaccine candidate for India and countries in the low-income group.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.